Production (Stage)
OS Therapies Incorporated
OSTX
$1.67
$0.042.45%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.64% | -14.00% | 17.15% | -- | -- |
| Total Depreciation and Amortization | -41.67% | -33.33% | -72.00% | -- | -- |
| Total Amortization of Deferred Charges | -58.28% | -67.99% | -65.34% | -- | -- |
| Total Other Non-Cash Items | 78.90% | 654.50% | 20.76% | -- | -- |
| Change in Net Operating Assets | -142.50% | -106.43% | -103.76% | -- | -- |
| Cash from Operations | -213.06% | -142.17% | -57.94% | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Investing | -- | -- | -100.00% | -- | -- |
| Total Debt Issued | -72.17% | -44.54% | -27.01% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 155.24% | 100.00% | 23.59% | -- | -- |
| Cash from Financing | 342.64% | 344.66% | 109.67% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,225.36% | 4,243.67% | 8,039.66% | -- | -- |